English | Español
Patient Daily | Apr 10, 2026

AbbVie maintains confidence in Skyrizi after FDA approval of Icotyde for plaque psoriasis
Patient Daily | Apr 10, 2026

Takeda restructuring could affect more than 600 US employees, company says
Patient Daily | Apr 10, 2026

Lilly and Baseline investigate GLP-1 drugs for substance use disorders as research grows
Patient Daily | Apr 10, 2026

Kardigan blood pressure drug advances after mixed Phase 2 trial results
Patient Daily | Apr 10, 2026

FDA expected to make key drug approval decisions in second quarter of 2026
Patient Daily | Apr 10, 2026

Kevin Tang returns as Aurinia CEO with $50 million offer for Kezar Life Sciences
Patient Daily | Apr 10, 2026

Study shows PSMA therapy can delay hormone treatment in prostate cancer patients
Patient Daily | Apr 10, 2026

Study finds inhaling disinfectant chemicals may cause lung injury in mice

Trending
Patient Daily | Apr 7, 2026

ProPublica examines impact of RFK Jr.'s vaccine policies on childhood disease risks
+ Regulatory
Patient Daily | Apr 9, 2026

Reason Foundation commentator on vaccine liability: 'Exposing vaccine makers to the machinations of trial lawyers will stymie the development of innovative vaccines'
+ Regulatory
Patient Daily | Apr 8, 2026

Columbia University Professor Masia on 340B: '340B has become a drug mark-up program. Hospitals buy drugs at low cost and sell them high'
+ Pharmaceuticals
Patient Daily | Apr 10, 2026

Researchers identify artemin as marker and target in feline osteoarthritis